CIMETIDINE INHIBITS IN-VIVO GROWTH OF HUMAN COLON-CANCER AND REVERSESHISTAMINE-STIMULATED IN-VITRO AND IN-VIVO GROWTH

Citation
Wj. Adams et al., CIMETIDINE INHIBITS IN-VIVO GROWTH OF HUMAN COLON-CANCER AND REVERSESHISTAMINE-STIMULATED IN-VITRO AND IN-VIVO GROWTH, Gut, 35(11), 1994, pp. 1632-1636
Citations number
25
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
GutACNP
ISSN journal
00175749
Volume
35
Issue
11
Year of publication
1994
Pages
1632 - 1636
Database
ISI
SICI code
0017-5749(1994)35:11<1632:CIIGOH>2.0.ZU;2-0
Abstract
The effect of histamine and cimetidine on the growth of four human col on cancer cell lines was studied. Histamine significantly stimulated t he uptake of tritiated thymidine in vitro in a dose dependent manner, to a maximum of 120% and 116% of controls for C170 and LIM2412, respec tively. This effect was antagonised by cimetidine, but not diphenhydra mine. Histamine also stimulated a dose dependent increase in cyclic ad enosine monophosphate accumulation in C170 cells, antagonised by cimet idine. When grown as subcutaneous xenografts in Balb/c nu/nu mice, cim etidine had a significant inhibitory effect on the same two cell lines . The final volume of C170 tumours in animals given cimetidine was 44% of controls. This response was dose dependent, plateauing at a cimeti dine dose of 50 mg/kg/day. The final volume of LIM2412 tumours in anim als given cimetidine was 60% of controls. Histamine administered local ly by a mini-osmotic pump stimulated C170 tumour growth to 164% of con trols, was antagonised by cimetidine at a dose of 200 mg/kg/day, but n ot by lower concentrations. Histamine has a trophic effect on at least two colorectal cancer cell lines in vivo and in vitro. As this effect is antagonised by cimetidine, it may be mediated via tumour histamine type 2 receptors.